RT Matteo Franceschetti (@m_franceschetti)BREAKING: We just raised $100M at @eightsleep to build the AI that finally fixes sleep.For decades, sleep has been passive. You lie down, close your eyes, and hope for the best. We’re changing that.Over 1B hours of biometric sleep data → distilled into fully autonomous AI that knows your body better than you do.We will do this in two ways:Step 1: Your personal Sleep Agent, running infinite nightly scenarios before they happen to deliver the most restorative sleep yo ...

Core Viewpoint - Jupiter Neurosciences, Inc. has announced the addition of Chris Webber as the second brand ambassador for its new longevity supplement line, Nugevia™, which is based on clinical science and innovative performance-driven technology [1][3]. Company Overview - Jupiter Neurosciences is a clinical-stage pharmaceutical company focused on addressing neuroinflammation and promoting healthy aging through a dual-path strategy that includes advancing therapeutics for CNS disorders and entering the consumer longevity market with Nugevia™ [7]. - The company’s proprietary JOTROL™ platform enhances the bioavailability of resveratrol, which is the foundation for both its therapeutic pipeline and the Nugevia™ product line [10]. Product Details - Nugevia™ features three initial formulations—GLO, MND, and PWR—designed to support cellular resilience through synergistic ingredients optimized for absorption via the JOTROL™ system [4]. - The Nugevia™ brand aims to tap into the rapidly growing longevity market, projected to reach $8 trillion by 2030, creating a revenue stream to support ongoing clinical development and enhance long-term shareholder value [5][6]. Scientific Validation - JOTROL™ has demonstrated over nine times higher bioavailability compared to traditional resveratrol products, as evidenced by a Phase I study published in reputable journals [9]. - The technology aims to provide pharmaceutical-grade bioavailability in the wellness space, targeting cognitive health, skin vitality, and cellular energy [10].

Longer Leash On Life: Inside The Dog Longevity Startup https://t.co/Q2C4MvCF38 https://t.co/hIrj71I4KA ...

Dr. Eric Topol’s longevity work identified daily habits to follow in a study of “super agers” who are healthy at ages 85 and above."I am taking my own advice," says Dr. Eric Topol, a 70-year-old cardiologist.He shares the tips that he follows: 🔗 https://t.co/qNaSFkwNHQ https://t.co/oqNSEQWUjV ...

Dr. Eric Topol’s longevity work identified daily habits to follow in a study of “super agers” who are healthy at ages 85 and above."I am taking my own advice," says Dr. Eric Topol, a 70-year-old cardiologist.He shares the tips that he follows: 🔗 https://t.co/m4a3jIaSrG https://t.co/MFrqYAMGf3 ...

Industry Focus - The article discusses a startup focused on dog longevity [1] Company Overview - The company is working on extending the lifespan of dogs [1]

What if dogs could live longer? Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional approval from the FDA next year. https://t.co/EHrbN6leYy (Photo: Ethan Pines For Forbes) #BillionDollarStartups https://t.co/X1Q9LGOnal ...

What if dogs could live longer and healthier lives? Loyal’s Celine Halioua has raised $135 million from top investors to develop canine longevity pills. https://t.co/jEy4vkwPr4 #BillionDollarStartups ...

What if dogs could live longer? Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional approval from the FDA next year. https://t.co/CB7XYURx5J (Photo: Ethan Pines For Forbes) #BillionDollarStartups https://t.co/upsGDD8jW1 ...

WATCH: This Next Billion-Dollar Startup Makes Longevity Drugs For Dogs #BillionDollarStartups https://t.co/lpMmB19VYh ...